Published: 19 May 2020
Author(s): José Gonzalez-Costello, Miguel Cainzos-Achirica, Josep Lupón, Nuria Farré, Pedro Moliner-Borja, Cristina Enjuanes, Marta de Antonio, Lara Fuentes, Carles Díez-López, Antoni Bayés-Genis, Nicolás Manito, Ramón Pujol, Josep Comin-Colet
Section: Original article

Iron deficiency (ID) affects up to 50% of patients with chronic heart failure (HF). ID in patients with HF has been shown to be an independent adverse prognostic factor [1,2], it is associated with decreased exercise capacity [3 and quality of life [4,5] and has therefore become a therapeutic target.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.